SHL Medical

A device should not ask the molecule to compromise. Magnitude’s distinct architecture creates additional flexibility around selected molecule and delivery requirements.

Large volume may start the conversation. But it rarely defines the complete delivery decision. That was reinforced in many conversations at recent pharma conferences. Customers were not only asking about capacity. We discussed evolving formulation and delivery requirements, the importance of the patient interaction, and what it takes to move a complete system forward. This is why we introduced Magnitude, SHL Medical’s cartridge-based, NIT-enabled autoinjector platform, available in dedicated 3.0 mL and 5.0 mL configurations. Its cartridge-based architecture create additional room around your selected molecule and the Needle Isolation Technology (NIT) expands your selected delivery needs. This is what “When more matters” means to us. Not simply more volume, but a platform designed around more of what the large-volume program may require. Learn more about Magnitude: https://lnkd.in/ez_UwA_3 #Magnitude #WhenMoreMatters

The cartridge creates flexibility around the selected molecule and delivery requirements. Needle Isolation Technology (NIT) translates that flexibility into an automatic familiar two-step injection

As volume and viscosity increase, delivery performance depends on more than the powerpack. Magnitude’s Needle Isolation Technology (NIT) provides an additional engineering lever through the fluid path, creating flexibility around selected cannula parameters according to program-specific requirements.

Large-volume programs do not all require the same capacity. Magnitude offers dedicated 3.0 mL and 5.0 mL configurations, allowing the format to be selected around the program.

Within SHL Medical, device development is connected to tooling, automation, manufacturing, final assembly, and testing, so industrial considerations enter the program early rather than after the design is fixed.